Detalles de la búsqueda
1.
Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.
Hepatology
; 62(4): 1047-58, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26147061
2.
Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.
J Infect Dis
; 210(12): 1881-5, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24907384
3.
A small-molecule inhibitor of hepatitis C virus infectivity.
Antimicrob Agents Chemother
; 58(1): 386-96, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24165192
4.
Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.
J Virol
; 85(8): 3978-85, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21289124
5.
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor.
Antivir Ther
; 19(7): 679-86, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24503447
6.
Generation and quantitation of infectious hepatitis C virus derived from cell culture (HCVcc).
Curr Protoc Pharmacol
; Chapter 13: Unit 13B.4, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21935897
7.
Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus.
Antiviral Res
; 83(2): 135-42, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19457562
8.
The NS5A protein of bovine viral diarrhea virus contains an essential zinc-binding site similar to that of the hepatitis C virus NS5A protein.
J Virol
; 80(15): 7450-8, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16840325
Resultados
1 -
8
de 8
1
Próxima >
>>